These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19552859)

  • 1. Pharmacotherapy for adult ADHD.
    Adler LA
    J Clin Psychiatry; 2009 May; 70(5):e12. PubMed ID: 19552859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult attention deficit/hyperactivity disorder in the ambulatory care setting.
    Hackett A; Joseph R; Robinson K; Welsh J; Nicholas J; Schmidt E
    JAAPA; 2020 Aug; 33(8):12-16. PubMed ID: 32740107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
    JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].
    Lehmkuhl G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():10-3; quiz 14. PubMed ID: 17724960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G; Vannucchi G
    Expert Opin Pharmacother; 2015; 16(14):2193-204. PubMed ID: 26364896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of ADHD in adults.
    Wilens TE
    CNS Spectr; 2008 May; 13(5 Suppl 8):11-3. PubMed ID: 18567133
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in understanding and treating ADHD.
    Antshel KM; Hargrave TM; Simonescu M; Kaul P; Hendricks K; Faraone SV
    BMC Med; 2011 Jun; 9():72. PubMed ID: 21658285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.
    Newcorn JH; Weiss M; Stein MA
    CNS Spectr; 2007 Aug; 12(8 Suppl 12):1-14; quiz 15-6. PubMed ID: 17667893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents.
    Childress AC; Berry SA
    Drugs; 2012 Feb; 72(3):309-25. PubMed ID: 22316347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
    Faraone SV; Wigal SB; Hodgkins P
    J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined treatment approach for adults with ADHD--results of an open study of 43 patients.
    Rostain AL; Ramsay JR
    J Atten Disord; 2006 Nov; 10(2):150-9. PubMed ID: 17085625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
    Kornfield R; Watson S; Higashi AS; Conti RM; Dusetzina SB; Garfield CF; Dorsey ER; Huskamp HA; Alexander GC
    Psychiatr Serv; 2013 Apr; 64(4):339-46. PubMed ID: 23318985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G; Newcorn JH
    Pediatr Clin North Am; 2011 Feb; 58(1):99-120, xi. PubMed ID: 21281851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.